We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 966 results
  1. Blood–brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia

    Objective

    We aim to investigate blood–brain barrier (BBB) dysfunction and myelin basic protein (MBP) in amyotrophic lateral sclerosis (ALS) with or...

    **-Yue Li, Zheng-Yi Cai, ... Li-Ying Cui in Neurological Sciences
    Article 26 November 2021
  2. Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury

    The aim of this study was to investigate if the biomarkers myelin basic protein (MBP) and neurofilament-H (NF-H) yielded informative value in...

    Simone Bohnert, Christoph Wirth, ... Michael Bohnert in International Journal of Legal Medicine
    Article Open access 24 April 2021
  3. Role of fenofibrate in multiple sclerosis

    Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of the central nervous system (CNS). The underlying...

    Ahmad A. Abulaban, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in European Journal of Medical Research
    Article Open access 09 February 2024
  4. Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography

    Purpose of Review

    Multiple sclerosis is characterized by a diverse and complex pathology. Clinical relapses, the hallmark of the disease, are...

    Matthew R. Brier, Farris Taha in Current Neurology and Neuroscience Reports
    Article 07 July 2023
  5. FcRn Inhibitor Therapies in Neurologic Diseases

    In the last decade, the landscape of treating autoimmune diseases has evolved with the emergence and approval of novel targeted therapies. Several...

    Nouf Alfaidi, Salama Karmastaji, ... Vera Bril in CNS Drugs
    Article 09 May 2024
  6. Molecular biomarkers for vascular cognitive impairment and dementia

    As disease-specific interventions for dementia are being developed, the ability to identify the underlying pathology and dementia subtypes is...

    Satoshi Hosoki, Gurpreet K. Hansra, ... Perminder S. Sachdev in Nature Reviews Neurology
    Article 13 November 2023
  7. Beneficial effects of ferulic acid in streptozotocin-induced diabetic neuropathy in male Wistar rats

    Objectives

    The available medications for diabetes mellitus (DM) are not sufficient to reverse the pathophysiological abnormalities and complications...

    Md. Fahim Ahmad, Tariq Aziz, ... Waseem A. Siddiqui in Nutrire
    Article 11 January 2024
  8. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications

    Purpose of Review

    Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system (CNS). Inflammatory attacks in MS...

    Tyrell J Simkins, Greg J Duncan, Dennis Bourdette in Current Neurology and Neuroscience Reports
    Article 09 April 2021
  9. White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency

    Vascular cognitive impairment and dementia (VCID) is the second most common form of dementia after Alzheimer’s disease (AD). Currently, the...

    **ngyong Chen, Ling Chen, ... Francesca-Fang Liao in Molecular Psychiatry
    Article Open access 10 August 2022
  10. Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries

    Approximately 15 million babies are born prematurely every year and many will face lifetime motor and/or cognitive deficits. Children born...

    Cindy Bokobza, Alice Jacquens, ... Juliette Van Steenwinckel in Journal of Neural Transmission
    Article Open access 06 November 2022
  11. Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis

    In multiple sclerosis (MS), sustained inflammatory activity can be visualized by iron-sensitive magnetic resonance imaging (MRI) at the edges of...

    Annika Hofmann, Nik Krajnc, ... Simon Hametner in Acta Neuropathologica
    Article Open access 16 September 2023
  12. AIM2 inflammasome mediates hallmark neuropathological alterations and cognitive impairment in a mouse model of vascular dementia

    Chronic cerebral hypoperfusion is associated with vascular dementia (VaD). Cerebral hypoperfusion may initiate complex molecular and cellular...

    Luting Poh, David Y. Fann, ... Thiruma V. Arumugam in Molecular Psychiatry
    Article 09 December 2020
  13. Endothelial cells and macrophages as allies in the healthy and diseased brain

    Diseases of the central nervous system (CNS) are often associated with vascular disturbances or inflammation and frequently both. Consequently,...

    Adam Denes, Cathrin E. Hansen, ... Markus Schwaninger in Acta Neuropathologica
    Article Open access 12 February 2024
  14. The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology

    Although the pathology of X-linked adrenoleukodystrophy (ALD) is well described, it represents the end-stage of neurodegeneration. It is still...

    Hemmo A.F. Yska, Marc Engelen, Marianna Bugiani in Orphanet Journal of Rare Diseases
    Article Open access 28 March 2024
  15. Determining Commonalities in the Experiences of Patients with Rare Diseases: A Qualitative Analysis of US Food and Drug Administration Patient Engagement Sessions

    Background

    Rare diseases are estimated to affect more than one in ten Americans. However, most patients with a rare disease face significant...

    Catherine Mease, Lewis J. Fermaglich, ... Kathleen L. Miller in The Patient - Patient-Centered Outcomes Research
    Article 13 October 2023
  16. Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a sco** review study

    Background

    Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system. This study aimed to evaluate the advantages and...

    Mohammad Khalafi, Amirmohammad Rezaei Rashnoudi, ... Kiarash Shirbandi in Egyptian Journal of Radiology and Nuclear Medicine
    Article Open access 17 January 2023
  17. Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage

    Objective

    Intracerebral hemorrhage (ICH) refers to predominant, sporadic, and non-traumatic bleeding in the brain parenchyma. The PI3K/AKT/mTOR...

    Kuldeep Singh Jadaun, Sidharth Mehan, ... Naif Alsuhaymi in Current Medical Science
    Article 26 January 2022
  18. Biochemical analyses for dental age estimation: a review

    Background

    For various legal and forensic scenarios, establishing an individual’s age, both living and dead, plays a crucial role. Various...

    Maitreyi Pillalamarri, Ravikanth Manyam, ... Satya Tejaswi Akula in Egyptian Journal of Forensic Sciences
    Article Open access 11 January 2022
  19. An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis

    Purpose

    For many patients, the multiple sclerosis (MS) diagnostic process can be lengthy, costly, and fraught with error. Recent research aims to...

    Marwa Kaisey, Ghazal Lashgari, ... Nancy L. Sicotte in Current Neurology and Neuroscience Reports
    Article 21 October 2022
  20. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis

    It has now been established that a perturbation in gut microbiome composition exists in multiple sclerosis (MS) and its interplay with the immune...

    Dimitrios C. Ladakis, Pavan Bhargava in CNS Drugs
    Article 24 January 2023
Did you find what you were looking for? Share feedback.